基本信息 产品详情 公司简介 推荐产品
网站主页 重组人蛋白OX40 LIGAND/TNFSF4/OX40L (N-6HIS) OX40 Ligand蛋白
  • 重组人OX40 Ligand/TNFSF4蛋白-ACROBiosystems百普赛斯
  • 重组人OX40 Ligand/TNFSF4蛋白-ACROBiosystems百普赛斯
  • 重组人OX40 Ligand/TNFSF4蛋白-ACROBiosystems百普赛斯

1/3

重组人OX40 Ligand/TNFSF4蛋白-ACROBiosystems百普赛斯

OX40 Ligand
询价 100ug 起订
500ug 起订
1000ug 起订
北京 更新日期:2024-07-15

北京百普赛斯生物科技股份有限公司

VIP1年
联系人:姚经理
手机:18514007688 拨打
邮箱:jiaxin.zhao@acrobiosystems.com

产品详情:

中文名称:
OX40 Ligand蛋白
英文名称:
OX40 Ligand
品牌:
百普赛斯
产地:
北京
保存条件:
-20°C to -70°C
纯度规格:
99.9%
产品类别:
重组蛋白
货号:
OX40 Ligand
用途范围:
药物开发等
规格:
100ug
是否进口:

Human OX40 Ligand / TNFSF4 Protein, His Tag, active trimer (MALS verified)

分子别名(Synonym

OX40L,TNFSF4,CD252,Glycoprotein Gp34,TXGP1,CD134 ligand,CD134L

表达区间及表达系统(Source

Human OX40 Ligand Protein, His Tag (OXL-H52Q8) is expressed from human 293 cells (HEK293). It contains AA Gln 51 - Leu 183 (Accession # NP_003317).

Predicted N-terminus: His

蛋白结构(Molecular Characterization

1.jpg

This protein carries a polyhistidine tag at the N-terminus.

The protein has a calculated MW of 16.9 kDa. The protein migrates as 25-30 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

内毒素(Endotoxin

Less than 1.0 EU per μg by the LAL method.

纯度(Purity

>90% as determined by SDS-PAGE.

>95% as determined by SEC-MALS.

制剂(Formulation

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

重构方法(Reconstitution

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

存储(Storage

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

-20°C to -70°C for 12 months in lyophilized state;

-70°C for 3 months under sterile conditions after reconstitution.

2.jpg

3.jpg

背景(Background

Tumor necrosis factor ligand superfamily member 4 (TNFSF4) is also known as glycoprotein Gp34, OX40 ligand (OX40L), TAX transcriptionally-activated glycoprotein 1 and CD252, which belongs to the tumor necrosis factor family. TNFSF4 is the ligand for CD134 and is expressed on such cells as DC2s (a subtype of dendritic cells) enabling amplification of Th2 cell differentiation. The interaction of TNFSF4-TNFSF4 is involved in the pathogenesis of multiple autoimmune and inflammatory diseases such as systemic lupus erythematosus (SLE), carotid artery disease and cancer. Furthermore, similar to other TNF superfamily members, membrane-bound OX40 Ligand (TNFSF4) exists as a homotrimer. Human TNFSF4 shares 46% amino acid sequence identity with its mouse counterpart.

OX40 Ligand;OX40 Ligand蛋白;TNFSF4重组蛋白;ACRO;百普赛斯;

公司简介

百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。

成立日期 (14年)
注册资本 8000万人民币
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂,试剂
主营行业 医药中间体,原料药,激素类,氨基糖苷类,中枢神经系统用药

内容声明
拨打电话 立即询价